A new briefing paper from Path to Smoke-Free examines the regulatory decisions Azerbaijan faces on nicotine pouches and why they will define its smoking trajectory for decades.
Azerbaijan will not be smoke-free until 2105. That is not a provocation. It is the output of the Path to Smoke-Free platform’s exponential decay model applied to the country’s current rate of decline. If nothing changes, Azerbaijan will spend the rest of this century slowly, expensively, and lethally working toward a target it could reach in a fraction of the time.
The comparison that makes the stakes legible is Sweden. Following Sweden’s pace of decline, Azerbaijan would reach smoke-free status by 2054. That is 51 years earlier. Following the combined pace of global leaders, the endpoint arrives by 2063, still 42 years ahead. Fifty-one years is not a policy nuance. It is the difference between a generation of preventable deaths and a generation that doesn’t have to die from a delivery mechanism for nicotine we already know how to replace.
In 2024, lung cancer deaths in Azerbaijan stood at 1,525, up from 981 in 2010. A 55% rise in fourteen years is what a country on the 2105 trajectory looks like.
Why 2026 Is the Moment
Two regulatory developments have converged to create a decisive inflection point. A comprehensive set of Technical Regulations covering nicotine and tobacco products is awaiting entry into force in 2026; and crucially, nicotine pouches were included as a separately defined product category for the first time. Simultaneously, a complete ban on vaping took effect on 1 April 2026, displacing roughly 300,000 devices sold monthly. Former vapour retailers are already repositioning as “snus and vapour stores.” Whether that displaced demand flows toward nicotine pouches or back to cigarettes depends almost entirely on the regulatory framework enacted in the next few months.
What Proportionate Regulation Actually Looks Like
Proportionate does not mean unregulated. Azerbaijan’s current market has allowed products with nicotine levels reaching 75, 150, and even higher milligrams per pouch — concentrations that serve no harm reduction purpose and generate exactly the moral panic that makes sensible policy harder. In December 2025, eight students were hospitalized in Baku in what media reported as a nicotine pouch poisoning. The Food Safety Agency determined the cause was flavored chewing gum. The damage to public understanding was real regardless. And it is a direct consequence of the information vacuum that unregulated markets create.
Regulation fills that vacuum. The Czech model established a 12 mg per pouch nicotine ceiling alongside youth access controls. Greece introduced digital age verification via mobile QR code with fines of up to €10,000 for violations. New Zealand built a licensed adult-only retail framework and saw underage vaping fall below levels in neighboring Australia, where the product is nominally banned. Meanwhile, adult smoking in New Zealand dropped from 15.1% in 2018 to 6.8% in 2025. Strict enforcement and legal access protect young people more effectively than prohibition does.
The Structural Problem No One Is Talking About
Nicotine pouches are sold through approximately 400 retail points in Azerbaijan. Cigarettes and heated tobacco are available through more than 12,000. That 1-to-30 ratio means the product most capable of displacing cigarettes is practically invisible where most smokers make their daily decisions. If the Technical Regulations permit mainstream retail access, that changes. If they don’t, the accessibility gap becomes a de facto barrier to the behavior change the policy nominally seeks to encourage.
Taxation matters equally. A meaningful price differential between cigarettes and pouches creates an economic pathway to switching that reinforces everything else. Azerbaijan currently applies no excise to nicotine pouches. How that changes in 2026 will carry real public health consequences.
The Burden Falls on Those Who Would Wait
The countries that have already integrated proportionate nicotine pouch regulation include Sweden, Czechia, the United Kingdom, New Zealand, and, in the region most comparable to Azerbaijan’s context, the UAE, Bahrain, and Saudi Arabia. If this approach is sound policy in Stockholm and Abu Dhabi, the burden of argument falls on those who would deny it to Baku.
That burden is not being met by the evidence. It is being filled by moral panic and regulatory inertia, which leads directly to 2105, and to continuing to accumulate 1,525 lung cancer deaths and 33,289 circulatory deaths every year while the smoke-free horizon drifts toward the end of the century.